Global Polymer Based Solubility Enhancement Excipients Market for OSDF 2017-2021
About Polymer Based Solubility Enhancement Excipients for OSDF
The behavior of drugs with regard to solubility has been one of the most crucial aspects of developing a formulation. Drug formulations are adversely affected by poor solubility and low permeability. Approximately 40% of the modern drugs that are marketed is classified by the Biopharmaceutical Classification System (BCS) into two subcategories of the low-solubility drugs. Additionally, a study on drug entities in development revealed that the percentage would increase to 80%. This inclination of the pharmaceutical industry toward low-solubility drugs will lead to the requirement of solubility enhancement excipients to increase the solubility of these drugs in the physiological system. Therefore, the rise in the production of low-solubility drug ingredients is directly proportional to the rise in the production of polymer-based solubility enhancement excipients for oral solid dosage forms (OSDF). Therefore, the success of a medication in the pharmaceutical industry depends principally on the function carried on by solubility enhancement excipients.
Technavio’s analysts forecast the global polymer based solubility enhancement excipients market for OSDF to grow at a CAGR of 16.56% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global polymer based solubility enhancement excipients market for OSDF for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of polymer based solubility enhancement excipients for OSDF.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Polymer Based Solubility Enhancement Excipients Market for OSDF 2017-2021
Technavio recognizes the following companies as the key players in the global olymer based solubility enhancement excipients market for osdf: Ashland, BASF, Dow Chemical, Evonik, and Shin-Etsu Chemical
Other Prominent Vendors in the market are: Clariant, Freund, Maple Biotech, Nisso America, Peter Cremer, SPI Pharma, and The Lubrizol Corporation
Commenting on the report, an analyst from Technavio’s team said: “The polymer-based solubility excipients market for OSDF is subject to supply contracts with clauses defining expectations in the guaranteed volumes, specification limits, and quality maintenance of the product with prior notification. For most of the global excipient vendors, this translates into custom manufacturing, and this practice of manufacturing custom-based excipients has been a trend in the market. Further, the production facilities and changes in operations are to be in accordance with the standards set by FDA drug product guidelines, which has resulted in the lingering trend. While few vendors work with contract manufacturing organizations (CMOs), independent CMOs that cater directly to pharmaceutical companies are on the rise.”
According to the report, the global polymer-based solubility enhancement excipients market for OSDF will grow at a CAGR of approximately 16.56% during the forecast period, which reflects the pipeline of drug entities under development. Further, the fact that poor solubility is one of the most common attributes of modern day drug entities gives the global polymer-based solubility enhancement excipients market for OSDF an opportunity to capitalize on the concern.
Further, the report states that the successful development of a solubility enhancing excipient is dependent on the nature of chemistry between the excipient and the API. However, there is a lack of availability of such information, including excipient-API relationship and molecular interactions. The development of a novel solubility enhancing excipient for new APIs also necessitates adequate information about such APIs. However, vendors in the market face the challenge of obtaining such information for APIs that are being developed. There is insufficient vendor-formulator collaboration in the market that restricts market growth.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit- https://www.technavio.com/report/global-plastics-polymers-and-elastomers-global-polymer-based-solubility-enhancement
Ashland, BASF, Dow Chemical, Evonik, Shin-Etsu Chemical, Clariant, Freund, Maple Biotech, Nisso America, Peter Cremer, SPI Pharma, and The Lubrizol Corporation